A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene
NCT ID: NCT02221349
Last Updated: 2020-09-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-08-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes
NCT02513212
A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
NCT03965039
Dentinal Hypersensitivity Reduction
NCT06244290
Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity
NCT02613117
Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity
NCT02152826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oxalate liquid & gel plus SnF2 paste
Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Stannous fluoride paste, self applied
Potassium oxalate
Professionally applied (liquid) and self applied (gel)
Stannous fluoride paste
Toothpaste used by subject
oxalate liquid & gel plus NaF paste
Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Sodium fluoride paste, self applied
Potassium oxalate
Professionally applied (liquid) and self applied (gel)
Sodium fluoride paste
Toothpaste used by subject
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Potassium oxalate
Professionally applied (liquid) and self applied (gel)
Sodium fluoride paste
Toothpaste used by subject
Stannous fluoride paste
Toothpaste used by subject
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provide written informed consent prior to participation and be given a signed copy of the informed consent form
* Complete a confidentiality disclosure agreement
* Be in good general health as determined by the Investigator/designee
* Have at least one tooth with a Schiff sensitivity score of at least 1 in response to the air challenge.
Exclusion Criteria
* Severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession
* Active treatment of periodontitis
* Fixed facial orthodontic appliances
* A history of kidney stones
* Known allergies to the following ingredients; aqua, glycerin, cellulose gum, dipotassium oxalate, carbomer, sodium hydroxide, sodium benzoate, and potassium sorbate
* Any diseases or conditions that might interfere with the safe completion of the study
* An inability to undergo any study procedures.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Procter and Gamble
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chad J Anderson, MS, DMD
Role: PRINCIPAL_INVESTIGATOR
Chad J Anderson DMD Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chad J Anderson DMD Inc
Fresno, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014069
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.